跳至主要内容
临床试验/IRCT20210612051545N3
IRCT20210612051545N3招募中1 期

evaluation of human placenta extract effectiveness in the treatment of skin wrinkles: A phase I/II clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 65 years(—)
性别
All

入选标准

  • Wrinkle lines on the face should be in the range of 3-5 based on Wrinkle Severity Rating Scale

排除标准

  • Suffering from uncontrolled chronic diseases including diabetes mellitus, underlying chronic liver, kidney and heart disease, chronic malnutrition, malignancy, coagulopathy or the use of anticoagulants, a history of autoimmune diseases and suffering from HBV, HIV, HCV viral infections
  • Any cosmetic procedure such as fat injection within a year and permanent filler, microneedling, RF, laser and other cases within the last 6 months, except for using cream.
  • Infection and any malignancy at the transplant recipient site
  • Failure to receive cells in the treatment area during the past year
  • Patients with vitiligo
  • Moderate to severe chronic skin diseases such as eczema and psoriasis
  • active acne
  • People who have had systemic retinoid treatment (within the last 6 months) or topical retinoid treatment (within the last 2 weeks
  • History of keloid
  • Women during pregnancy and breastfeeding
  • Patients undergoing radiotherapy and chemotherapy

研究者

相似试验